Component
Human cardiac diastolic function
Human cardiac diastolic function. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
No significant treatment benefit in measured diastolic function was found.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/pectin-research/33532663.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9600257cc318b4b6bdb0c2d95c4b42f8644220c06bb0581dc604ca4e7d7ba051", "start_char": 14495, "end_char": 19456, "text_sha256": "7914ef3745e7ff82580f8ed02f013628d44c7461d6ce4dbc254b273561c8a732"}
- experimental_model
- Double-blind randomized placebo-controlled proof-of-concept trial
- exposure
- 68 randomized participants with hypertension and elevated galectin-3; Pectasol-C 4.8 g three times/day for six months; 52 had complete biomarker data
- limitations
- Target inhibition was not established by dosing alone. Surrogate endpoints and incomplete follow-up; no demonstrated heart-failure treatment benefit.
- nutrient_topic
- Pectin research collection; topical membership is not evidence of a direct dietary effect. · Pectin, structurally heterogeneous plant polysaccharides
- organism
- Homo sapiens
- plain_language
- A measurable improvement in heart relaxation was not established.
- primary_references
- [pectin-p33532663] Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension. (2021). https://pubmed.ncbi.nlm.nih.gov/33532663/ DOI: 10.1016/j.jacbts.2020.10.006
- tissue_or_cell_type
- Blood collagen markers, cardiac and vascular assessments
Pectin: metabolism, signaling and nutrient connections (2026-09-17) · lines 1062–1073
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind randomized placebo-controlled proof-of-concept trial · source_derived_draft · unverified_draft
### pectin-mcp-cardiac-null No significant treatment benefit in measured diastolic function was found. Condition category: normal nutrient_topic: Pectin research collection; topical membership is not evidence of a direct dietary effect. plain_language: A measurable improvement in heart relaxation was not established. organism: Homo sapiens tissue_or_cell_type: Blood collagen markers, cardiac and vascular assessments experimental_model: Double-blind randomized placebo-controlled proof-of-concept trial limitations: Target inhibition was not established by dosing alone. Surrogate endpoints and incomplete follow-up; no demonstrated heart-failure treatment benefit. exposure: 68 randomized participants with hypertension and elevated galectin-3; Pectasol-C 4.8 g three times/day for six months; 52 had complete biomarker data evidence_span: {"source_cache": "artifacts/pectin-research/33532663.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9600257cc318b4b6bdb0c2d95c4b42f8644220c06bb0581dc604ca4e7d7ba051", "start_char": 14495, "end_char": 19456, "text_sha256": "7914ef3745e7ff82580f8ed02f013628d44c7461d6ce4dbc254b273561c8a732"} [pectin-p33532663] Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension. (2021). https://pubmed.ncbi.nlm.nih.gov/33532663/ DOI: 10.1016/j.jacbts.2020.10.006
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.